Fritextsökning
Innehållstyper
-
They’re all doing it – buying drug research
It is not easy to navigate the complex infrastructure for drug development in Sweden, where various contract players exist alongside the pharmaceutical companies.
-
Creatives substanser möjlig bot av EHEC
Visar positiv effekt mot E. coli-bakterier. Nu ska substanserna testas mot infektionssjukdomen EHEC.
-
Efter positiva resultat för Valneva: ”Ansökan till EMA skickas så snart som möjligt”
Efter att ha stoppats av Storbritannien ser det nu ljusare ut för Valnevas covid-19-vaccinkandidat sedan positiva fas III-resultat presenterats. Nu väntar ansök...
-
Reproducibility and handling in focus with new electronic pipette
The Eppendorf Xplorer electronic pipette has been developed with reproducibility in mind.
-
Changeable proteins cause nerve disease
An incorrectly folded protein is one of the reasons behind the nerve disease ALS, according to new research. But the protein does not have structural errors all...
-
Svenska bolag på infektionsmässa i USA
Flera svenskar är på plats på ICAAC som hålls just nu i San Fransisco, USA. Biotech Sweden har pratat med Björn Ursing från Västerbotten Investment Agency.
-
Prenatal testing breakthrough
For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.
-
Cate Poulsen, Qiagen
Why are you going to Scanlab and Biotech Forum?
-
Column: Repurposing as a golden ticket to approval
"Hopefully, in the end, patients will be winners by receiving on-label treatments for which benefit-risk has been properly assessed." In a column Marie Gårdmark...
-
Hemarbete ökar risken för nätfiske i läkemedelsföretag
Allt fler hackerförsök inom läkemedelsbranschen riktar sig mot anställdas mobiltelefoner.
-
Lucka 4 - vem finns här?
Bakom den fjärde luckan önskar sig vd:n att föreläsaren och succéförfattaren ska slå en signal...
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
Marie Gårdmark: Big data evidence generation drives change in the EU regulatory system
Rapid developments in technology have led to the possibility for the generation and analysis of vast volumes of data. Will the availability of big data lead to ...
-
Teams up with leading dermatologist
Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.
-
Academy for a new turn at work
Are you qualified within life science, but unemployed? Here is your chance for a new career, in high demand.
-
Drug development creates new challenges for regulators
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
EMA till Amsterdam
Det stod klart efter kvällens omröstning i Allmänna rådet i Bryssel. Sverige åkte ut redan i första röstningsomgången.
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...
-
Researchers goes to the bottom of the brain
Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.
-
How to get visitors to your booth
Food, ball throwing and laser engraved pens. There are many tricks to attract visitors to the stands at Scanlab.
-
Grönt ljus för Neurovives studie
Lundabolaget har fått ja på sin ansökan. ”En viktig milstolpe” säger bolagets medicinska chef.
-
It´s time to establish relations
Communication with the patient is the key to future healthcare, writes Hanna Brodda, editor in chief of Life Science Sweden.
-
Welcome to wonderful Copenhagen
Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...